ABWCX
Price
$15.38
Change
+$0.02 (+0.13%)
Updated
Jun 3 closing price
Net Assets
416.39M
RLEFX
Price
$35.65
Change
+$0.15 (+0.42%)
Updated
Jun 3 closing price
Net Assets
241.95B
Interact to see
Advertisement

ABWCX vs RLEFX

Header iconABWCX vs RLEFX Comparison
Open Charts ABWCX vs RLEFXBanner chart's image
AB All Market Total Return C
Price$15.38
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets416.39M
American Funds American Balanced R5E
Price$35.65
Change+$0.15 (+0.42%)
VolumeN/A
Net Assets241.95B
ABWCX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABWCX vs. RLEFX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABWCX is a Buy and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 242B vs. ABWCX (416M). ABWCX pays higher dividends than RLEFX: ABWCX (2.24) vs RLEFX (2.09). ABWCX was incepted earlier than RLEFX: ABWCX (22 years) vs RLEFX (10 years). ABWCX (1.87) is less costly to investors than RLEFX (0.39). ABWCX is a more actively managed with annual turnover of: 182.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than ABWCX: RLEFX (250) vs ABWCX (2500). ABWCX annual gain was more profitable for investors over the last year : 8.57 vs. RLEFX (7.97). RLEFX return over 5 years is better than : 37.20 vs. ABWCX (14.94).
ABWCXRLEFXABWCX / RLEFX
Total Expense Ratio1.860.39477%
Annual Report Gross Expense Ratio1.870.39479%
Fund Existence22 years10 years-
Gain YTD4.1364.30896%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets416M242B0%
Annual Yield % from dividends2.242.09107%
Returns for 1 year8.577.97107%
Returns for 3 years13.2223.0857%
Returns for 5 years14.9437.2040%
Returns for 10 years21.04N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SBFM1.550.13
+9.15%
Sunshine Biopharma Inc
ACHV4.210.31
+7.95%
Achieve Life Sciences
REPX27.581.51
+5.79%
Riley Exploration Permian
USAC26.311.07
+4.24%
USA Compression Partners LP
WES38.050.35
+0.93%
Western Midstream Partners LP